These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37325165)

  • 1. Successful treatment of severe
    Xu Y; Li Z; Ouyang L; Su Y; Wang C
    SAGE Open Med Case Rep; 2023; 11():2050313X231178050. PubMed ID: 37325165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experience.
    Hardak E; Oren I; Dann EJ; Yigla M; Faibish T; Rowe JM; Avivi I
    Acta Haematol; 2012; 127(2):110-4. PubMed ID: 22178955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low incidence of pneumocystis pneumonia utilizing PCR-based diagnosis in patients with B-cell lymphoma receiving rituximab-containing combination chemotherapy.
    Barreto JN; Ice LL; Thompson CA; Tosh PK; Osmon DR; Dierkhising RA; Plevak MF; Limper AH
    Am J Hematol; 2016 Nov; 91(11):1113-1117. PubMed ID: 27472910
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Tiantian C; Jin Y; Jing Z; Jing F; Xiaoyan J
    J Int Med Res; 2022 Jun; 50(6):3000605221105358. PubMed ID: 35751409
    [No Abstract]   [Full Text] [Related]  

  • 5. Pneumocystis jirovecii pneumonia in diffuse large B-cell Lymphoma treated with R-CHOP.
    Lee JY; Kang M; Suh KJ; Kim JW; Kim SH; Kim JW; Kim YJ; Song KH; Kim ES; Kim HB; Lee KW; Kim JH; Bang SM; Lee JS; Lee JO
    Mycoses; 2021 Jan; 64(1):60-65. PubMed ID: 32970331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Ibrahim A; Chattaraj A; Iqbal Q; Anjum A; Rehman MEU; Aijaz Z; Nasir F; Ansar S; Zangeneh TT; Iftikhar A
    Avicenna J Med; 2023 Jan; 13(1):23-34. PubMed ID: 36969352
    [No Abstract]   [Full Text] [Related]  

  • 8. VV-ECMO combined with prone position ventilation in the treatment of Pneumocystis jirovecii pneumonia: A case report.
    Jia L; Zhang Z; Bai Y; Du Q
    Medicine (Baltimore); 2022 Jan; 101(1):e28482. PubMed ID: 35029898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy.
    Kim T; Choi SH; Kim SH; Jeong JY; Woo JH; Kim YS; Sung H; Kim MN; Yoon DH; Suh C; Lee SO
    Ann Hematol; 2013 Jan; 92(2):231-8. PubMed ID: 23053189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-center retrospective analysis of Pneumocystis jirovecii pneumonia in patients after deceased donor renal transplantation.
    Zou J; Wang T; Qiu T; Zhou J; Chen Z; Ma X; Jin Z; Xu Y; Zhang L
    Transpl Immunol; 2022 Jun; 72():101593. PubMed ID: 35367619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hidden consequences: Uncovering belimumab's role in the development of
    Ng M; Mackay M; Gautam-Goyal P; Goyal S; Vikraman PK
    Lupus; 2023 Sep; 32(10):1227-1230. PubMed ID: 37497619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of
    Wu HH; Fang SY; Chen YX; Feng LF
    World J Clin Cases; 2022 Mar; 10(9):2743-2750. PubMed ID: 35434110
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Wu WH; Hui TC; Wu QQ; Xu CA; Zhou ZW; Wang SH; Zheng W; Yin QQ; Li X; Pan HY
    World J Clin Cases; 2021 Oct; 9(28):8595-8601. PubMed ID: 34754873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
    Avino LJ; Naylor SM; Roecker AM
    Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis jirovecii pneumonia in HIV-uninfected, rituximab treated non-Hodgkin lymphoma patients.
    Wei KC; Sy C; Wu SY; Chuang TJ; Huang WC; Lai PC
    Sci Rep; 2018 May; 8(1):8321. PubMed ID: 29844519
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Bukamur HS; Karem E; Fares S; Al-Ourani M; Al-Astal A
    Respir Med Case Rep; 2018; 25():174-176. PubMed ID: 30186757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia.
    Jin F; Liu XH; Chen WC; Fan ZL; Wang HL
    Int J Infect Dis; 2019 Nov; 88():141-148. PubMed ID: 31442630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-Infection Pneumonia with
    Xie D; Xian Y; You J; Xu W; Fan M; Bi X; Zhang K
    Infect Drug Resist; 2021; 14():879-888. PubMed ID: 33692629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from Multiple Infections Such as Lymphoma Complicated with Pneumocystis Infection: A Case Report.
    Wang H; Lang Y; Cai X; Gao L; Yang S; Jin J
    Infect Drug Resist; 2024; 17():1583-1588. PubMed ID: 38681899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients.
    Tu GW; Ju MJ; Xu M; Rong RM; He YZ; Xue ZG; Zhu TY; Luo Z
    Nephrology (Carlton); 2013 Nov; 18(11):736-42. PubMed ID: 24571744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.